Oncology Central

Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?

0

Cancers attributed to ovarian origin are relatively uncommon in the USA general population, accounting for only 2.6% of cancers in women [1]. Yet, this disease is responsible for 14.2% of the cancer deaths in American women [1]. Over 21,000 women are expected to be diagnosed in the USA with ovarian cancer during the next year [1].

When detected and treated in its earliest stage, those who may be diagnosed with ovarian cancer have relatively good prognosis for survival; however, the majority of ovarian cancers have not been diagnosed until quite advanced when the outlook for relapse-free survival has been gravely disappointing [1,2].

To view restricted content, please:
Share:

Leave A Comment